Switch from Quats

Rethink Your Disinfection Program. Simplify the Standard.

Compare your current quat-based products with EraDOCate on pathogen coverage, contact time, staff training, chemical handling, and total operating cost. EraDOCate offers a quat-free, EPA-registered disinfection platform built around peracetic acid and hydrogen peroxide.

A better buying decision starts with three questions.

1Does each product cover the organisms you need?
2How many products and procedures does your team manage?
3What does your full disinfection program cost?

Compare the Whole Program

Quat-based products vary. The right comparison uses the exact EPA label, your facility's workflow, and measurable operating requirements.

Evaluation
Current quat-based program
EraDOCate platform
Pathogen coverage
Claims vary by product. High-risk organisms may require an additional disinfectant.
Broad label-listed claims, including defined 4-minute protocols for C. difficile spores and C. auris.
Contact time
Different products may have different wet contact times.
Many label-listed organisms have a 1-minute protocol. Others require longer, organism-specific contact times.
Inventory & training
Facilities may stock multiple products, directions, and training materials.
Evaluate opportunities to consolidate products and teach one OCEAN operating framework.
Handling & safety
Controls vary by product type, application, label, and SDS.
Controlled dilution, PPE, training, and concentration checks support a consistent workflow.
Operating cost
Review purchase price, storage, freight, staff time, packaging, and waste.
Compare the total program to find opportunities for standardization and savings.

This comparison describes potential operational differences, not guaranteed savings or universal performance differences. Follow the current product label and SDS for each use.

Three Reasons to Reevaluate

Be ready for difficult organisms

CDC advises using products with an EPA-registered C. auris claim. EraDOCator-60 provides a label-defined option for C. auris and C. difficile.

Reduce daily complexity

One product platform, closed-loop dilution, and OCEAN training may simplify purchasing, stocking, and staff procedures.

Review the total footprint

Compare chemical handling, worker exposure controls, packaging, freight, storage, and waste alongside efficacy and cost.

Evidence Matters. So Does Fair Comparison.

CDC notes concerns about disinfectants relying solely on quaternary ammonium compounds for C. auris. Some products containing quats also appear on EPA List P, so the registered claim and exact formula matter more than the ingredient category alone.

Research also examines QAC exposure and environmental pathways. Neither quat-based products nor peracetic acid and hydrogen peroxide are hazard-free. Compare labels, SDS, PPE, application methods, and facility needs.

A Practical Way to Evaluate the Switch

Start with your current program. Review the fit before making a purchasing decision.

1

Review

List your disinfectants, pathogen requirements, surfaces, training needs, and annual purchasing costs.

2

Compare

Match EPA label claims and application requirements. Evaluate dilution, safety procedures, and workflow.

3

Decide

Identify a practical implementation plan and compare the expected operational value for your facility.

See What Your Current Program Could Simplify.

Share your facility type and current disinfectants. EraDOCate will help you review product fit, documentation, training, and purchasing considerations.

i

Product Use and Results Disclaimer

EraDOCate products are EPA-registered disinfectants. EPA registration does not imply EPA endorsement and does not replace the requirement to read and follow the product label, SDS, facility protocols, and applicable infection-prevention policies. Contact times, organisms, use sites, dilution, application methods, PPE, storage, disposal, and safety requirements vary by product and label. Testimonials, pilot results, field examples, and case references reflect specific settings and may not represent expected results in every facility. EraDOCate does not replace clinical judgment, regulatory guidance, or facility infection-control oversight.